AG
AVNS

Aperio Group’s Avanos Medical AVNS Stock Holding History

Aperio Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.84M Buy
40,111
+9,620
+32% +$400K 0.01% 1283
2020
Q3 		$1.01M Sell
30,491
-2,515
-8% -$80.4K ﹤0.01% 1438
2020
Q2 		$970K Sell
33,006
-10,999
-25% -$318K ﹤0.01% 1425
2020
Q1 		$1.19M Buy
44,005
+16,402
+59% +$490K 0.01% 1236
2019
Q4 		$930K Buy
27,603
+2,388
+9% +$86.5K ﹤0.01% 1470
2019
Q3 		$945K Sell
25,215
-3,166
-11% -$121K ﹤0.01% 1422
2019
Q2 		$1.24M Sell
28,381
-2,965
-9% -$127K 0.01% 1296
2019
Q1 		$1.34M Sell
31,346
-3,726
-11% -$167K 0.01% 1216
2018
Q4 		$1.57M Sell
35,072
-3,816
-10% -$200K 0.01% 1085
2018
Q3 		$2.66M Buy
38,888
+1,427
+4% +$91.8K 0.01% 905
2018
Q2 		$2.15M Buy
37,461
+2,106
+6% +$111K 0.01% 998
2018
Q1 		$1.63M Buy
35,355
+1,474
+4% +$70K 0.01% 1086
2017
Q4 		$1.56M Buy
33,881
+1,607
+5% +$73.9K 0.01% 1095
2017
Q3 		$1.45M Buy
32,274
+2,212
+7% +$94.4K 0.01% 1077
2017
Q2 		$1.18M Buy
30,062
+1,991
+7% +$75.2K 0.01% 1151
2017
Q1 		$1.07M Buy
28,071
+898
+3% +$35K 0.01% 1142
2016
Q4 		$1M Buy
27,173
+5,021
+23% +$179K 0.01% 1126
2016
Q3 		$768K Buy
22,152
+3,758
+20% +$132K 0.01% 1229
2016
Q2 		$598K Buy
18,394
+2,342
+15% +$71.7K ﹤0.01% 1291
2016
Q1 		$461K Buy
16,052
+556
+4% +$14.8K ﹤0.01% 1406
2015
Q4 		$518K Sell
15,496
-171
-1% -$5.32K ﹤0.01% 1323
2015
Q3 		$446K Sell
15,667
-5,880
-27% -$205K ﹤0.01% 1364
2015
Q2 		$873K Buy
21,547
+1,128
+6% +$50.6K 0.01% 1036
2015
Q1 		$1M Sell
20,419
-1,299
-6% -$60.2K 0.01% 937
2014
Q4 		$988K Buy
+21,718
New +$853K 0.01% 913

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aperio Group's AVNS Position: Q4 2020 in Review

Aperio Group increased its Avanos Medical (AVNS) stake by 32% in Q4 2020, buying an estimated $400K and bringing the position to 40,111 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #1283.

Aperio Group first reported a position in AVNS in Q4 2014 and has held it in 25 quarters since. The position peaked at $2.66M in Q3 2018. 281 funds tracked by Wall St. Rank hold AVNS as of Q4 2020.

  • Aperio Group held 40,111 shares of Avanos Medical worth $1.84M as of Q4 2020.
  • Aperio Group bought 9,620 Avanos Medical shares in Q4 2020, an estimated $400K.
  • Avanos Medical made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1283 holding.
  • Aperio Group first reported a position in Avanos Medical in Q4 2014 and has held it in 25 quarters since.
  • Aperio Group's Avanos Medical position peaked at $2.66M in Q3 2018.
  • 281 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.